Company / Operating Income per Share
NEUROONE MEDICAL TECHNOLOGIES Corp Operating Income per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.39
FY2025
5-year range
-$0.85 / -$0.39
FY2021-FY2025
Trend
+22.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has increased for 3 consecutive years, from $-0.85 in FY2022 to $-0.39 in FY2025.
Based on SEC 10-K filings.
-0.39 in FY2025.
Improved from $-0.62 to $-0.39 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 22.8% year-over-year.
- Peak operating income per share was recorded in FY2014.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.39 | +22.8% |
| FY2024 | -$0.50 | +19.2% |
| FY2023 | -$0.62 | +27.3% |
| FY2022 | -$0.85 | -28.3% |
| FY2021 | -$0.66 | -10780.1% |
| FY2016 | -$0.01 | +13.9% |
| FY2015 | -$0.01 | -43.1% |
| FY2014 | -$0.00 | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026